Item 1A. Risk Factors
ITEM 1A. RISK FACTORS
There have been no material
changes to our risk factors since those disclosed in “Part I, Item 1A. Risk Factors” of our Form 10-K, except as set forth
below.
Our financial
condition raises substantial doubt as to our ability to continue as a going concern.
Our
independent registered public accounting firm previously expressed substantial doubt regarding our ability to continue as a going concern
in its audit report dated March 12, 2026, for the year ended December 31, 2025. This conclusion was based on recurring losses from operations,
negative cash flows, and the need to raise additional capital to support our ongoing activities.
Although
we cannot predict with certainty all of our particular short-term cash uses or the timing or amount of cash requirements, management has
concluded that there is substantial doubt about our ability to continue as a going concern as discussed in “Note 3 – Going
Concern” of our unaudited condensed consolidated financial statements included in this report. Our recurring losses, negative cash
flow and the uncertainties surrounding our ability to execute and to realize our planned revenue growth and expected benefits from our
operational improvement initiatives, could impact our future profitability and liquidity, which could in the future raise substantial
doubt about our ability to continue to execute our operating plan as currently intended and require us to seek additional financing. If
adequate funds or additional financings are not available, if and when needed, or if the terms of potential funding sources are unfavorable,
our business, financial condition, and results of operations could be materially and adversely affected. Additionally, our financial statements
have been prepared assuming that we will continue to operate as a going concern, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. Thus, our financial statements do not include any adjustments that might
be necessary if we are unable to continue as a going concern.
We have a history
of operating losses, and we may not be able to generate sufficient revenue to achieve and sustain profitability.
We have not achieved profitability and have incurred losses since inception.
For the quarter ended March 31, 2026, we recorded a net loss of $4,338,495. For the year ended December 31, 2025, we recorded a net loss
of $17,590,392. As of March 31, 2026, we had an accumulated deficit of $60,356,156. While we have experienced revenue growth over recent
periods, we may not be able to sustain or increase our growth or achieve profitability in the future. We intend to continue to invest
diligently in sales and marketing efforts. In addition, we expect to incur significant additional legal, accounting, compliance and other
expenses related to public company compliance and the expansion of our business. If our revenue fails to grow at a rate faster than these
increases in our operating expenses, we will not be able to achieve and maintain profitability in future periods. As a result, we may
continue to generate losses. Additionally, we may encounter unforeseen operating expenses, difficulties, complications, delays, and other
unknown factors that may result in losses in future periods. If these losses exceed our expectations or our revenue growth expectations
are not met in future periods, our financial performance will be harmed.
34
If we are unable to satisfy the continued
listing requirements of the Nasdaq, our common stock could be delisted and the price and liquidity of our common stock may be adversely
affected.
Our common stock may lose
value and could be delisted from Nasdaq due to several factors or a combination of such factors. While our common stock is currently listed
on Nasdaq, we can give no assurance that we will be able to satisfy the continued listing requirements of Nasdaq in the future, including,
but not limited to, the corporate governance requirements and the minimum closing bid price requirement or the minimum equity requirement.
On May 20, 2025, we received
a deficiency letter from the Nasdaq Listing Qualifications Department of Nasdaq notifying us that, for 30 consecutive business days, the
closing bid price of our common stock was below the minimum $1.00 per share required for continued listing pursuant to Nasdaq Listing
Rule 5550(a)(2). The Nasdaq deficiency letter had no immediate effect on the listing of our common stock, and we were initially given
180 calendar days, or until November 17, 2025, to regain compliance with Nasdaq Listing Rule 5550(a)(2), which was extended by an additional
180 calendar days, or May 18, 2026.
On March 30, 2026, the Board
approved a 1-for-25 reverse stock split of our outstanding common stock, which is expected to become effective on or around April 30,
2026, subject to the filing and effectiveness of an amendment to our certificate of incorporation with the Secretary of State of Delaware.
The reverse stock split was previously approved by our stockholders at the 2025 annual meeting of stockholders We anticipate to receive
written confirmation from Nasdaq notifying us that we have regained compliance with Nasdaq Listing Rule 5550(a)(2) on or around May 14,
2026, assuming that our stock price remains above $1.00 for a period of at least 10 business days, but there is no assurance that we will
receive such written confirmation from Nasdaq at or around such date, or at all.
If we were to be delisted,
we would expect our common stock to be traded in the over-the-counter market which could adversely affect the liquidity of our common
stock. Additionally, we could face significant material adverse consequences, including:
● a limited availability of market quotations for our common
stock;
● a decreased ability to issue additional securities or obtain
additional financing in the future;
● reduced liquidity for our stockholders;
● potential loss of confidence by customers, collaboration partners
and employees; and
● loss of institutional investor interest.
In the event of a delisting,
we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our common stock to
become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below
the Nasdaq minimum bid price requirement, or prevent future non-compliance with Nasdaq’s listing requirements.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.